BIM
BIIB icon

BlackRock Investment Management’s Biogen BIIB Stock Holding History

BlackRock Investment Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-13,900
Closed -$4.25M – 4038
2014
Q1 		$4.25M Buy
+13,900
New +$4.41M 0.01% 1486

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock Investment Management's BIIB Position: Q4 2016 in Review

BlackRock Investment Management increased its Biogen (BIIB) stake by 17% in Q4 2016, buying an estimated $47.1M and bringing the position to 1,107,758 shares worth $314M. The position accounts for 0.36% of the portfolio, ranked #45.

BlackRock Investment Management first reported a position in BIIB in Q2 2013 and has held it in 15 quarters since. The position peaked at $367M in Q2 2014. 1,026 funds tracked by Wall St. Rank hold BIIB as of Q4 2016.

  • BlackRock Investment Management held 1,107,758 shares of Biogen worth $314M as of Q4 2016.
  • BlackRock Investment Management bought 158,870 Biogen shares in Q4 2016, an estimated $47.1M.
  • Biogen made up 0.36% of BlackRock Investment Management's portfolio in Q4 2016, its #45 holding.
  • BlackRock Investment Management first reported a position in Biogen in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Investment Management's Biogen position peaked at $367M in Q2 2014.
  • 1,026 funds tracked by Wall St. Rank held Biogen as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.